{
    "id": 2034,
    "fullName": "RAD50 L1237F",
    "impact": "missense",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "RAD50 L1237F lies in the D-loop of the Rad50 protein (PMID: 24934408). L1237F reduces expression of Rad50 protein and is defective in ATM signallng in yeast and mammalian cell assays (PMID: 24934408).",
            "references": [
                {
                    "id": 880,
                    "pubMedId": 24934408,
                    "title": "Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24934408"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 10111,
        "geneSymbol": "RAD50",
        "terms": [
            "RAD50",
            "hRad50",
            "NBSLD",
            "RAD502"
        ]
    },
    "variant": "L1237F",
    "createDate": "10/01/2014",
    "updateDate": "06/30/2016",
    "referenceTranscriptCoordinates": {
        "id": 126394,
        "transcript": "NM_005732",
        "gDna": "chr5:g.132640762C>T",
        "cDna": "c.3709C>T",
        "protein": "p.L1237F",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1137,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a patient with metastatic small cell cancer of the ureter harboring RAD50 L1237F achieved a complete and durable response to Camptosar (irinotecan) plus AZD7762 treatment (PMID: 24934408).",
            "molecularProfile": {
                "id": 1972,
                "profileName": "RAD50 L1237F"
            },
            "therapy": {
                "id": 1584,
                "therapyName": "AZD7762 + Irinotecan",
                "synonyms": null
            },
            "indication": {
                "id": 6886,
                "name": "ureter small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 880,
                    "pubMedId": 24934408,
                    "title": "Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24934408"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 1972,
            "profileName": "RAD50 L1237F",
            "profileTreatmentApproaches": [
                {
                    "id": 4392,
                    "name": "CHK Inhibitor (Pan)",
                    "profileName": "RAD50 L1237F"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 126394,
            "transcript": "NM_005732",
            "gDna": "chr5:g.132640762C>T",
            "cDna": "c.3709C>T",
            "protein": "p.L1237F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}